Skip navigation
Agenda

The World’s Largest and Highest Acclaimed Life Sciences Event for CFOs, Controllers and Finance Executives

March 20-22, 2019
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

DAY ONE WEDNESDAY, MARCH 20, 2019

9:00

Pre-Congress Registration

10:00

CHOOSE FROM 3 PRE-CONGRESS BREAKOUT SESSIONS (I-III)

I. 101 Boot Camp

Gain foundational knowledge across a broad spectrum of central topics. The Boot Camp is a valuable session for newcomers to the industry or for those looking for a refresher on complex and changing standards and regulations.

Michael Lombardo
Partner
Deloitte & Touche LLP

Silvia Bassily
Senior Manager
Deloitte & Touche LLP

Rich Holtz
Senior Manager
Deloitte & Touche LLP

II. New Product Commercialization/Launch Strategies

Poise for success in advance of a new product launch by gaining commercialization best practices and market entry success factors.

Graham Poles
Partner
PwC

Zachary Weisbly
Director
PwC

Manmeet S. Soni
Chief Financial Officer
Alnylam Pharmaceuticals, Inc.

Chris Prentiss
Chief Accounting Officer
Adamas Pharmaceuticals, Inc.

III. Industry-Only Roundtable Session

Participate in a hot topic exchange and industry-only roundtable, as accounting leaders from life science companies delve into pressing matters, emerging accounting guidance issues, shared challenges and areas of disparity in practice. Limited to Corporate Preparers only, and suggested for senior-level Technical Accounting, Controllership and Reporting professionals.

Speaker TBD

10:45

Networking and Refreshment Break

12:00

General Registration

1:00

CHOOSE BETWEEN 2 NETWORKING SUMMITS (A-B)

A. Newcomer’s Orientation and Welcome Summit

SUMMIT DISCUSSION LEADERS:

James D’Arreca
Senior Vice President and
Chief Accounting Officer
Allergan plc

Robert Owens
Vice President and Chief Accountant
BMS

Stephen Rivera
Vice President, Global Technical Accounting Advisory Services and Policy
Johnson & Johnson

 
B. Women’s Leadership Summit

SUMMIT DISCUSSION LEADERS:

Laura Robinette
US Pharmaceutical and
Life Sciences Assurance Leader
PwC

Toni Lockett Cromwell
Partner
PwC

DISCUSSION CONTRIBUTORS:

Gisele Dion
Senior Vice President,
Chief Accounting Officer and Controller
Shire

Jill McConnell
Chief Financial Officer
Covance

Cynthia Schwalm
retired CEO, Ipsen;
current Biotech Board Member

Jennifer Ziolkowski
Chief Financial Officer
Solid Biosciences

2:00

Networking and Refreshment Break

GENERAL SESSION

2:30

Chairperson’s Welcoming Remarks

Cathy Engelbert
CEO
Deloitte

2:45

CEO Fireside Chat — Candid Conversation on Key Business and Industry Topics

Cathy Engelbert
CEO
Deloitte

Heather Bresch
CEO
Mylan

3:30

CFO KEYNOTE PANEL Leading in Finance and Navigating the Course of Change

MODERATOR:

Laura Robinette
US Pharmaceutical and Life Sciences Assurance Leader
PwC

PANELISTS:

Blaise Coleman
Chief Financial Officer
Endo

Bryan Reasons
Chief Financial Officer
Impax Labs/Amneal

Paolo Tombesi
Chief Financial Officer
Insmed Incorporated

Mark W. Hahn
Chief Financial Officer
Dova Pharmaceuticals, Inc.

4:30

REGULATORY INSIGHTS PANEL Making Strides in the Relevance and Effectiveness of Financial Reporting

MODERATOR:

Christine Davine
Deputy Managing Partner – Quality & Professional Practice
Deloitte & Touche LLP

PANELISTS:

James G. Kaiser
Board Member
PCAOB

Sagar Teotia
Deputy Chief Accountant
U.S. Securities and Exchange Commission

5:15

Industry Spotlight — SEC Insights and
Comment Letter Reviews of Life Science and Health Companies

James Rosenberg
Senior Assistant Chief Accountant, Office of Health Care and Insurance
U.S. Securities and Exchange Commission

Christine Davine
Deputy Managing Partner – Quality & Professional Practice
Deloitte & Touche LLP

5:40

Close of Day One

OPENING NIGHT RECEPTION COMMENCES immediately following the final session on day one Hosted by: Ernst & Young

DAY TWO THURSDAY, MARCH 21, 2019

6:00

“Rocky Run”   Hosted by: PwC

Join PwC and industry colleagues in a morning “Rocky Run”. Participants depart the hotel at 6am and run just under 2 miles to the Philadelphia Art Museum, ascending the famous Rocky Steps and taking a photo with Rocky’s statue. Do not miss this traditional Philadelphia right of passage! Return transportation provided.

7:00

Breakfast

8:00

Co-Chairs’ Welcome and Opening Remarks

Jeff Ellis
Partner, U.S. Life Sciences and Healthcare Audit Leader
Deloitte & Touche LLP

8:15

WALL STREET AND INVESTMENT PANEL Impactful Deals and Breakthroughs Impacting the Life Science Marketplace

MODERATER:

Pamela Yanakopulos
Partner, Capital Market and Accounting Advisory
PwC

PANELISTS:

Tony Gibney
Executive Vice President and Chief Business Officer
Achillion Pharmaceuticals, Inc.

Jeffrey Schwartz
Managing Director, Life Sciences
Bain Capital

Arvind Kush
Managing Director, Healthcare Investment Banking
Bank of America Merrill Lynch

9:00

Pricing, Reimbursement and Outcomes-Based Contracting Models —
An Inflection Point of Change for Today’s Life Science Landscape

Jason Helgerson
Fellow
United States of Care

Sasha Richardson
Executive Director – Advisory Lifesciences, Commercial Strategy
Ernst & Young LLP

9:40

Value-Based Healthcare and Implications for Finance and Accounting Teams

Mark Drozdowski
Partner, National Audit Leader, Life Sciences
KPMG

10:20

Networking and Refreshment Break

10:30

LUMINARY SEGMENT Digital Transformation and Innovation within Healthcare and Life Sciences

MODERATED BY:

Tim Gordon
Global FAAS Life Sciences Leader
Ernst & Young LLP

PANEL:

Brian Garcia
Chief Technology Officer
EngagedIN;
former CTO
Aetna

Michael Sturmer
Senior Vice President, Health Services Segment
Livongo

Dina Katabi
Professor of Electrical Engineering and Computer Science
and Director of the MIT Center for Wireless Networks
and Mobile Computing
MIT

Bank of America Merrill Lynch logo

12:50

Networking Luncheon Hosted by:

1:50

CHOOSE FROM 4 CONCURRENT WORKSHOPS (A-D)

A Credit Losses — Standard Changes and Implementation Considerations

Erik Bradbury
Partner, Financial Accounting Advisory Services
Ernst & Young LLP

Joseph Soviero
Executive Director
FAAS

B Corporate Tax Reform Implications

Benjamin Proce
New York Metro Pharma and Life Sciences Tax Leader
PwC

Kathleen Michael
US Health Industries Tax Leader
PwC

C M&A and Licensing —
The Art and Science of Valuations

Andreas Chrysostomou
Managing Director, Global Leader – Healthcare Life Sciences Industry
Duff & Phelps

D Digital Technologies, Automation and
Advanced Analytics in Finance

Brad Schulte
Senior Manager, Life Sciences Advisory Services
Deloitte & Touche LLP

Alex Smith
Partner
Deloitte & Touche LLP

2:40

Networking and Refreshment Break Hosted by:

3:10

CHOOSE FROM 4 CONCURRENT WORKSHOPS (E-H)

E Lease Accounting — ASC 842 Implementation

Christopher Nyers
Partner
CFGI

F GTN Models and Frameworks

Michael Makovec
Partner
Deloitte & Touche LLP

G Maximizing Capital Efficiency and R&D Productivity to Fuel Innovation in BioPharma

Alasdair Milton
Vice President, Life Sciences at Parthenon
Ernst & Young LLP

Arda Ural, PhD
Partner, Life Sciences, Transaction Advisory Services
Ernst & Young LLP

Prem Tumkosit
Managing Director, Merck Global Health Innovation Fund, LLC
Merck Global Health Innovation Group

Michael Kostelansky
Director, Global Business Development
Daiichi Sankyo

H Accounting for Collaborations

Kelly MacDonald
Senior Director, Financial Planning and Analysis
Ironwood Pharmaceuticals

Tim Kocses
Director, Corporate Technical Accounting
Bristol-Myers Squibb Company

4:00

Coffee Break

4:20

CHOOSE FROM 3 CONCURRENT SUMMITS (I-K)

I Business Transformation and
Next-Generation Finance

Candice Cantelli Meklis
Vice President
Archetype

Patrick Coyle
Vice President of Financial Planning and Analysis
Insmed

J Divestitures and
Portfolio Optimization Strategies

Mitesh Maheshwari
Executive Director, Americas Financial Accounting Advisory
Ernst & Young LLP

Subin Baral
Life Sciences Transactions Partner
Ernst & Young LLP

Carl Stanzione
Senior Director of Finance, A&D
Johnson & Johnson

Paul DeBartolo
Vice President, Finance Portfolio Management & Optimization
Pfizer

Fred Munsch
Vice President, Assistant Controller
Bausch Health

K Payer Negotiations for Improved Profitability
— A Role Play Exercise

Murray Kay
Trainer; former SVP and CFO, Solvay Pharmaceuticals;
former Commercial Controller, AbbVie & Abbott Laboratories

5:20

Close of Day Two

Please Join Us for a Cocktail Reception Immediately Following the Close of Workshops Hosted by: Deloitte logo

DAY THREE FRIDAY, MARCH 22, 2019

7:15

Breakfast

TRACKED PROGRAMMING

8:15

CHOOSE BETWEEN 3 CONCURRENT TRACKS (I-III)

TRACK I LARGE COMPANY SESSIONS

TRACK CHAIR:

Dennis Howell
Partner
Deloitte & Touche LLP

8:15

Track Chairperson’s Opening Remarks

8:30

OPENING LEADERSHIP PANEL Accounting and SEC Reporting Hot Topics — Key Considerations for
Corporate Controllers and Chief Accountants in the Year Ahead

MODERATOR:

Ryan Dolan
Partner
CFGI

PANELISTS:

Kevin MacKay
Vice President, Controller and Chief Accounting Officer
Pfizer

James D’Arreca
Senior Vice President and Chief Accounting Officer
Allergan plc

Gisele Dion
Senior Vice President, Chief Accounting Officer and Controller
Taketa

Stephen Rivera
Vice President, Global Technical Accounting Advisory Services and Policy
Johnson & Johnson

9:15

PANEL Critical Audit Matters — A Look at the New Auditor’s Report and
Key Implications for Corporate Preparers

MODERATOR:

Jeff Ellis
Partner, U.S. Life Sciences and Healthcare Audit Leader
Deloitte & Touche LLP

PANELISTS:

Matt Busch
Executive Director, Corporate Accounting
Amgen

Sabrina Basu
External Reporting, Technical Accounting and Internal Controls
Ironwood Pharmaceuticals

10:00

Networking and Refreshment Break

10:30

Leases —
Next Steps to Optimize Organizational Processes and Systems for ASC842

Melissa Bird
Senior Manager, FAAS
Ernst & Young LLP

Kevin MacKay
Vice President, Controller and Chief Accounting Officer
Pfizer

Meghan Crossman
Director of Technical Accounting
Zoetis

11:15

Technology-Enabled Carve-Outs and Divestitures

Shurjo K. Sen
Deals Partner
PwC

Robert Owens
Vice President and Chief Accountant
BMS

TRACK II EMERGING COMPANY SESSIONS

TRACK CHAIR:

Brian Jobe
Partner
Deloitte & Touche LLP

8:15

Track Chairperson’s Opening Remarks

8:30

OPENING LEADERSHIP PANEL Scaling for Growth and Taking a Company Commercial —
Pearls of Wisdom from CFOs

MODERATOR:

William Roberts
Partner
Ernst & Young LLP

PANELISTS:

Rhonda Chicko
Chief Financial Officer
Scholar Rock

Chad Cohen
Chief Financial Officer
Adaptive Biotechnologies

9:15

Strategies for Middle Market Companies to Succeed in an Ultra-Competitive Marketplace — Leadership, Governance and Stakeholder Engagement

Todd Berry
Assurance Partner and National Co-Leader, Life Sciences
BDO USA LLP

Tom Ziemba, PhD
Managing Director
BDO USA LLP

10:00

Networking and Refreshment Break

10:30

PANEL Capital Creation, Success Runways and Strategic Resource Allocation for
Early to Mid-Stage Companies

MODERATOR:

Ravi Raghunathan
Partner
CohnReznick LLP

PANELISTS:

Ted Myles
Executive Vice President and Chief Financial Officer
AMAG Pharmaceuticals, Inc.

Dominic Piscitelli
Chief Financial Officer
AnaptysBio

Stephen Garbacz
Senior Vice President, Finance and Operations
Spero Therapeutics

11:15

Managing Third-Party Oversight and Mitigating Risks with
Service Provider Relationships

Speaker TBA

TRACK III DEVICE AND HEALTH TECH SESSIONS

TRACK CHAIR:

John Sichak
Partner
PwC

8:15

Track Chairperson’s Opening Remarks

8:30

OPENING LEADERSHIP PANEL Key Accounting and Financial Reporting Matters —
Practical Strategies and Insights for Device Companies

MODERATOR:

John Sichak
Partner
PwC

PANELISTS:

Thomas Spoerel
Vice President of Finance and Controller
BD

Emily Collins
Director, Technical Accounting and SEC Reporting
Boston Scientific

Mary Wilcox
Chief Accounting Officer
Medtronic

William E. Berry Jr.
Vice President, Corporate Controller and
Principal Accounting Officer
Stryker

9:15

Tax Strategies and Related Issues for Medical Device Companies

Mark Drozdowski
Partner, National Audit Leader, Life Sciences
KPMG

10:00

Networking and Refreshment Break

10:30

Complying with the EU MDR Regulations —
Strategies for Finance and Accounting Executives

Caroline West
Global Chief Compliance Officer
Olympus Corporation (Invited)

11:15

Innovations, M&A, Evolution and Disruption in the Health Tech Market

Peter Micca
Partner, Life Sciences and Healthcare
Deloitte & Touche LLP(Invited)

12:00

Close of Tracks and Networking Luncheon

1:00

CLOSING SYMPOSIA (A-B)

A Automation and Blockchain — Impact to Forecasting, Financial Planning and Other Processes

Mathew Harrowing
Senior Manager, FAAS – Digital Growth Platform Leader
Ernst & Young LLP

Rick Capasso
Executive Director, Americas Financial Accounting Advisory Services
Ernst & Young LLP

B The Future Workforce — Strategies to Empower the Team, Elevate Talent and Cultivate a Winning Culture

Randy Brown
Principal
PwC Advisory

Marla Graeber
Principal, Health Industries People and Change Practice Leader
PwC

2:00

Close of Congress

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE WEDNESDAY, MARCH 20, 2019

9:00

Pre-Congress Registration

10:00

CHOOSE FROM 3 PRE-CONGRESS BREAKOUT SESSIONS (I-III)

I. 101 Boot Camp

Gain foundational knowledge across a broad spectrum of central topics. The Boot Camp is a valuable session for newcomers to the industry or for those looking for a refresher on complex and changing standards and regulations.

Michael Lombardo
Partner
Deloitte & Touche LLP

Silvia Bassily
Senior Manager
Deloitte & Touche LLP

Rich Holtz
Senior Manager
Deloitte & Touche LLP

II. New Product Commercialization/Launch Strategies

Poise for success in advance of a new product launch by gaining commercialization best practices and market entry success factors.

Graham Poles
Partner
PwC

Zachary Weisbly
Director
PwC

Manmeet S. Soni
Chief Financial Officer
Alnylam Pharmaceuticals, Inc.

Chris Prentiss
Chief Accounting Officer
Adamas Pharmaceuticals, Inc.

III. Industry-Only Roundtable Session

Participate in a hot topic exchange and industry-only roundtable, as accounting leaders from life science companies delve into pressing matters, emerging accounting guidance issues, shared challenges and areas of disparity in practice. Limited to Corporate Preparers only, and suggested for senior-level Technical Accounting, Controllership and Reporting professionals.

Speaker TBD

10:45

Networking and Refreshment Break

12:00

General Registration

1:00

CHOOSE BETWEEN 2 NETWORKING SUMMITS (A-B)

A. Newcomer’s Orientation and Welcome Summit

SUMMIT DISCUSSION LEADERS:

James D’Arreca
Senior Vice President and
Chief Accounting Officer
Allergan plc

Robert Owens
Vice President and Chief Accountant
BMS

Stephen Rivera
Vice President, Global Technical Accounting Advisory Services and Policy
Johnson & Johnson

 
B. Women’s Leadership Summit

SUMMIT DISCUSSION LEADERS:

Laura Robinette
US Pharmaceutical and
Life Sciences Assurance Leader
PwC

Toni Lockett Cromwell
Partner
PwC

DISCUSSION CONTRIBUTORS:

Gisele Dion
Senior Vice President,
Chief Accounting Officer and Controller
Shire

Jill McConnell
Chief Financial Officer
Covance

Cynthia Schwalm
retired CEO, Ipsen;
current Biotech Board Member

Jennifer Ziolkowski
Chief Financial Officer
Solid Biosciences

2:00

Networking and Refreshment Break

GENERAL SESSION

2:30

Chairperson’s Welcoming Remarks

Cathy Engelbert
CEO
Deloitte

2:45

CEO Fireside Chat — Candid Conversation on Key Business and Industry Topics

Cathy Engelbert
CEO
Deloitte

Heather Bresch
CEO
Mylan

3:30

CFO KEYNOTE PANEL Leading in Finance and Navigating the Course of Change

MODERATOR:

Laura Robinette
US Pharmaceutical and Life Sciences Assurance Leader
PwC

PANELISTS:

Blaise Coleman
Chief Financial Officer
Endo

Bryan Reasons
Chief Financial Officer
Impax Labs/Amneal

Paolo Tombesi
Chief Financial Officer
Insmed Incorporated

Mark W. Hahn
Chief Financial Officer
Dova Pharmaceuticals, Inc.

4:30

REGULATORY INSIGHTS PANEL Making Strides in the Relevance and Effectiveness of Financial Reporting

MODERATOR:

Christine Davine
Deputy Managing Partner – Quality & Professional Practice
Deloitte & Touche LLP

PANELISTS:

James G. Kaiser
Board Member
PCAOB

Sagar Teotia
Deputy Chief Accountant
U.S. Securities and Exchange Commission

5:15

Industry Spotlight — SEC Insights and
Comment Letter Reviews of Life Science and Health Companies

James Rosenberg
Senior Assistant Chief Accountant, Office of Health Care and Insurance
U.S. Securities and Exchange Commission

Christine Davine
Deputy Managing Partner – Quality & Professional Practice
Deloitte & Touche LLP

5:40

Close of Day One

OPENING NIGHT RECEPTION COMMENCES immediately following the final session on day one Hosted by: Ernst & Young

DAY TWO THURSDAY, MARCH 21, 2019

6:00

“Rocky Run”   Hosted by: PwC

Join PwC and industry colleagues in a morning “Rocky Run”. Participants depart the hotel at 6am and run just under 2 miles to the Philadelphia Art Museum, ascending the famous Rocky Steps and taking a photo with Rocky’s statue. Do not miss this traditional Philadelphia right of passage! Return transportation provided.

7:00

Breakfast

8:00

Co-Chairs’ Welcome and Opening Remarks

Jeff Ellis
Partner, U.S. Life Sciences and Healthcare Audit Leader
Deloitte & Touche LLP

8:15

WALL STREET AND INVESTMENT PANEL Impactful Deals and Breakthroughs Impacting the Life Science Marketplace

MODERATER:

Pamela Yanakopulos
Partner, Capital Market and Accounting Advisory
PwC

PANELISTS:

Tony Gibney
Executive Vice President and Chief Business Officer
Achillion Pharmaceuticals, Inc.

Jeffrey Schwartz
Managing Director, Life Sciences
Bain Capital

Arvind Kush
Managing Director, Healthcare Investment Banking
Bank of America Merrill Lynch

9:00

Pricing, Reimbursement and Outcomes-Based Contracting Models —
An Inflection Point of Change for Today’s Life Science Landscape

Jason Helgerson
Fellow
United States of Care

Sasha Richardson
Executive Director – Advisory Lifesciences, Commercial Strategy
Ernst & Young LLP

9:40

Value-Based Healthcare and Implications for Finance and Accounting Teams

Mark Drozdowski
Partner, National Audit Leader, Life Sciences
KPMG

10:20

Networking and Refreshment Break

10:30

LUMINARY SEGMENT Digital Transformation and Innovation within Healthcare and Life Sciences

MODERATED BY:

Tim Gordon
Global FAAS Life Sciences Leader
Ernst & Young LLP

PANEL:

Brian Garcia
Chief Technology Officer
EngagedIN;
former CTO
Aetna

Michael Sturmer
Senior Vice President, Health Services Segment
Livongo

Dina Katabi
Professor of Electrical Engineering and Computer Science
and Director of the MIT Center for Wireless Networks
and Mobile Computing
MIT

Bank of America Merrill Lynch logo

12:50

Networking Luncheon Hosted by:

1:50

CHOOSE FROM 4 CONCURRENT WORKSHOPS (A-D)

A Credit Losses — Standard Changes and Implementation Considerations

Erik Bradbury
Partner, Financial Accounting Advisory Services
Ernst & Young LLP

Joseph Soviero
Executive Director
FAAS

B Corporate Tax Reform Implications

Benjamin Proce
New York Metro Pharma and Life Sciences Tax Leader
PwC

Kathleen Michael
US Health Industries Tax Leader
PwC

C M&A and Licensing —
The Art and Science of Valuations

Andreas Chrysostomou
Managing Director, Global Leader – Healthcare Life Sciences Industry
Duff & Phelps

D Digital Technologies, Automation and
Advanced Analytics in Finance

Brad Schulte
Senior Manager, Life Sciences Advisory Services
Deloitte & Touche LLP

Alex Smith
Partner
Deloitte & Touche LLP

2:40

Networking and Refreshment Break Hosted by:

3:10

CHOOSE FROM 4 CONCURRENT WORKSHOPS (E-H)

E Lease Accounting — ASC 842 Implementation

Christopher Nyers
Partner
CFGI

F GTN Models and Frameworks

Michael Makovec
Partner
Deloitte & Touche LLP

G Maximizing Capital Efficiency and R&D Productivity to Fuel Innovation in BioPharma

Alasdair Milton
Vice President, Life Sciences at Parthenon
Ernst & Young LLP

Arda Ural, PhD
Partner, Life Sciences, Transaction Advisory Services
Ernst & Young LLP

Prem Tumkosit
Managing Director, Merck Global Health Innovation Fund, LLC
Merck Global Health Innovation Group

Michael Kostelansky
Director, Global Business Development
Daiichi Sankyo

H Accounting for Collaborations

Kelly MacDonald
Senior Director, Financial Planning and Analysis
Ironwood Pharmaceuticals

Tim Kocses
Director, Corporate Technical Accounting
Bristol-Myers Squibb Company

4:00

Coffee Break

4:20

CHOOSE FROM 3 CONCURRENT SUMMITS (I-K)

I Business Transformation and
Next-Generation Finance

Candice Cantelli Meklis
Vice President
Archetype

Patrick Coyle
Vice President of Financial Planning and Analysis
Insmed

J Divestitures and
Portfolio Optimization Strategies

Mitesh Maheshwari
Executive Director, Americas Financial Accounting Advisory
Ernst & Young LLP

Subin Baral
Life Sciences Transactions Partner
Ernst & Young LLP

Carl Stanzione
Senior Director of Finance, A&D
Johnson & Johnson

Paul DeBartolo
Vice President, Finance Portfolio Management & Optimization
Pfizer

Fred Munsch
Vice President, Assistant Controller
Bausch Health

K Payer Negotiations for Improved Profitability
— A Role Play Exercise

Murray Kay
Trainer; former SVP and CFO, Solvay Pharmaceuticals;
former Commercial Controller, AbbVie & Abbott Laboratories

5:20

Close of Day Two

Please Join Us for a Cocktail Reception Immediately Following the Close of Workshops Hosted by: Deloitte logo

DAY THREE FRIDAY, MARCH 22, 2019

7:15

Breakfast

TRACKED PROGRAMMING

8:15

CHOOSE BETWEEN 3 CONCURRENT TRACKS (I-III)

TRACK I LARGE COMPANY SESSIONS

TRACK CHAIR:

Dennis Howell
Partner
Deloitte & Touche LLP

8:15

Track Chairperson’s Opening Remarks

8:30

OPENING LEADERSHIP PANEL Accounting and SEC Reporting Hot Topics — Key Considerations for
Corporate Controllers and Chief Accountants in the Year Ahead

MODERATOR:

Ryan Dolan
Partner
CFGI

PANELISTS:

Kevin MacKay
Vice President, Controller and Chief Accounting Officer
Pfizer

James D’Arreca
Senior Vice President and Chief Accounting Officer
Allergan plc

Gisele Dion
Senior Vice President, Chief Accounting Officer and Controller
Taketa

Stephen Rivera
Vice President, Global Technical Accounting Advisory Services and Policy
Johnson & Johnson

9:15

PANEL Critical Audit Matters — A Look at the New Auditor’s Report and
Key Implications for Corporate Preparers

MODERATOR:

Jeff Ellis
Partner, U.S. Life Sciences and Healthcare Audit Leader
Deloitte & Touche LLP

PANELISTS:

Matt Busch
Executive Director, Corporate Accounting
Amgen

Sabrina Basu
External Reporting, Technical Accounting and Internal Controls
Ironwood Pharmaceuticals

10:00

Networking and Refreshment Break

10:30

Leases —
Next Steps to Optimize Organizational Processes and Systems for ASC842

Melissa Bird
Senior Manager, FAAS
Ernst & Young LLP

Kevin MacKay
Vice President, Controller and Chief Accounting Officer
Pfizer

Meghan Crossman
Director of Technical Accounting
Zoetis

11:15

Technology-Enabled Carve-Outs and Divestitures

Shurjo K. Sen
Deals Partner
PwC

Robert Owens
Vice President and Chief Accountant
BMS

TRACK II EMERGING COMPANY SESSIONS

TRACK CHAIR:

Brian Jobe
Partner
Deloitte & Touche LLP

8:15

Track Chairperson’s Opening Remarks

8:30

OPENING LEADERSHIP PANEL Scaling for Growth and Taking a Company Commercial —
Pearls of Wisdom from CFOs

MODERATOR:

William Roberts
Partner
Ernst & Young LLP

PANELISTS:

Rhonda Chicko
Chief Financial Officer
Scholar Rock

Chad Cohen
Chief Financial Officer
Adaptive Biotechnologies

9:15

Strategies for Middle Market Companies to Succeed in an Ultra-Competitive Marketplace — Leadership, Governance and Stakeholder Engagement

Todd Berry
Assurance Partner and National Co-Leader, Life Sciences
BDO USA LLP

Tom Ziemba, PhD
Managing Director
BDO USA LLP

10:00

Networking and Refreshment Break

10:30

PANEL Capital Creation, Success Runways and Strategic Resource Allocation for
Early to Mid-Stage Companies

MODERATOR:

Ravi Raghunathan
Partner
CohnReznick LLP

PANELISTS:

Ted Myles
Executive Vice President and Chief Financial Officer
AMAG Pharmaceuticals, Inc.

Dominic Piscitelli
Chief Financial Officer
AnaptysBio

Stephen Garbacz
Senior Vice President, Finance and Operations
Spero Therapeutics

11:15

Managing Third-Party Oversight and Mitigating Risks with
Service Provider Relationships

Speaker TBA

TRACK III DEVICE AND HEALTH TECH SESSIONS

TRACK CHAIR:

John Sichak
Partner
PwC

8:15

Track Chairperson’s Opening Remarks

8:30

OPENING LEADERSHIP PANEL Key Accounting and Financial Reporting Matters —
Practical Strategies and Insights for Device Companies

MODERATOR:

John Sichak
Partner
PwC

PANELISTS:

Thomas Spoerel
Vice President of Finance and Controller
BD

Emily Collins
Director, Technical Accounting and SEC Reporting
Boston Scientific

Mary Wilcox
Chief Accounting Officer
Medtronic

William E. Berry Jr.
Vice President, Corporate Controller and
Principal Accounting Officer
Stryker

9:15

Tax Strategies and Related Issues for Medical Device Companies

Mark Drozdowski
Partner, National Audit Leader, Life Sciences
KPMG

10:00

Networking and Refreshment Break

10:30

Complying with the EU MDR Regulations —
Strategies for Finance and Accounting Executives

Caroline West
Global Chief Compliance Officer
Olympus Corporation (Invited)

11:15

Innovations, M&A, Evolution and Disruption in the Health Tech Market

Peter Micca
Partner, Life Sciences and Healthcare
Deloitte & Touche LLP(Invited)

12:00

Close of Tracks and Networking Luncheon

1:00

CLOSING SYMPOSIA (A-B)

A Automation and Blockchain — Impact to Forecasting, Financial Planning and Other Processes

Mathew Harrowing
Senior Manager, FAAS – Digital Growth Platform Leader
Ernst & Young LLP

Rick Capasso
Executive Director, Americas Financial Accounting Advisory Services
Ernst & Young LLP

B The Future Workforce — Strategies to Empower the Team, Elevate Talent and Cultivate a Winning Culture

Randy Brown
Principal
PwC Advisory

Marla Graeber
Principal, Health Industries People and Change Practice Leader
PwC

2:00

Close of Congress